{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:51:38Z","timestamp":1789159898387,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010146","name":"Alzheimer Research Initiative","doi-asserted-by":"publisher","award":["16004"],"award-info":[{"award-number":["16004"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017722","name":"Johannes and Frieda Marohn Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["01ED1501B"],"award-info":[{"award-number":["01ED1501B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["01ED1501C"],"award-info":[{"award-number":["01ED1501C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["2226\/13\\u20131"],"award-info":[{"award-number":["2226\/13\\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bbr.2022.114020","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T21:59:26Z","timestamp":1658354366000},"page":"114020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Alpha synuclein processing by MMP-3 \u2013 implications for synucleinopathies"],"prefix":"10.1016","volume":"434","author":[{"given":"Alexandra","family":"Bluhm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Schrempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Moceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Stieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Feja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von H\u00f6rsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Hartlage-R\u00fcbsamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Ro\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.bbr.2022.114020_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jnc.13249","article-title":"Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies","volume":"139","author":"Villar-Piqu\u00e9","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2022.114020_bib2","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2022.114020_bib3","doi-asserted-by":"crossref","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell biology and pathophysiology of \u03b1-synuclein","volume":"8","author":"Burr\u00e9","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbr.2022.114020_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01276421","article-title":"Pattern of brain destruction in Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"103","author":"Braak","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2022.114020_bib5","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1074\/jbc.REV120.011743","article-title":"The emerging role of \u03b1-synuclein truncation in aggregation and disease","volume":"295","author":"Sorrentino","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2022.114020_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.598446","article-title":"Current evidence for a bidirectional loop between the lysosome and alpha-synuclein proteoforms","volume":"8","author":"Wildburger","year":"2020","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.bbr.2022.114020_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u03b1-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbr.2022.114020_bib8","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2022.114020_bib9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/brain\/awx056","article-title":"Glycation potentiates \u03b1-synuclein-associated neurodegeneration in synucleinopathies","volume":"140","author":"Vicente Miranda","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2022.114020_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/jnc.14721","article-title":"Effects of alpha-synuclein post-translational modifications on metal binding","volume":"150","author":"Gonz\u00e1lez","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2022.114020_bib11","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of \u03b1-synuclein carboxy-terminus on fibril formation in vitro","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbr.2022.114020_bib12","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of \u03b1-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbr.2022.114020_bib13","doi-asserted-by":"crossref","first-page":"22670","DOI":"10.1074\/jbc.M501508200","article-title":"A precipitating role for truncated \u03b1-synuclein and the proteasome in \u03b1-synuclein aggregation: Implications for pathogenesis of Parkinson disease","volume":"280","author":"Liu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2022.114020_bib14","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.3390\/ijms22115450","article-title":"Proteolytic \u03b1-synuclein cleavage in health and disease","volume":"22","author":"Bluhm","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2022.114020_bib15","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1523\/JNEUROSCI.4346-04.2005","article-title":"Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia","volume":"25","author":"Kim","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2022.114020_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1096\/fj.06-5865com","article-title":"A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation","volume":"21","author":"Kim","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bbr.2022.114020_bib17","doi-asserted-by":"crossref","first-page":"14168","DOI":"10.1074\/jbc.M111.222430","article-title":"Role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death","volume":"286","author":"Choi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2022.114020_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/10454411930040020401","article-title":"Matrix metalloproteinases: a review","volume":"4","author":"Birkedal-Hansen","year":"1993","journal-title":"Crit. Rev. Oral. Biol. Med."},{"key":"10.1016\/j.bbr.2022.114020_bib19","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.3390\/ijms20123077","article-title":"Post-translational modification-dependent activity of matrix metalloproteinases","volume":"20","author":"Madzharova","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bbr.2022.114020_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbr.2022.114020_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4062\/biomolther.2012.20.2.133","article-title":"Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders","volume":"20","author":"Kim","year":"2012","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.bbr.2022.114020_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1471-4159.2010.07082.x","article-title":"Role of matrix metalloproteinase-3 in neurodegeneration","volume":"116","author":"Kim","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2022.114020_bib23","doi-asserted-by":"crossref","first-page":"25216","DOI":"10.1074\/jbc.M503341200","article-title":"Proteolytic cleavage of extracellular secreted alpha-synuclein via matrix metalloproteinases","volume":"280","author":"Sung","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2022.114020_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.expneurol.2008.10.010","article-title":"Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases","volume":"215","author":"Levin","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2022.114020_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-021-02349-5","article-title":"A glutaminyl cyclase-catalyzed alpha-synuclein modification identified in human synucleinopathies","volume":"142","author":"Hartlage-R\u00fcbsamen","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2022.114020_bib26","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1073\/pnas.88.22.10059","article-title":"Primary structure and functional expression of a glutaminyl cyclase","volume":"88","author":"Pohl","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbr.2022.114020_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2826.1995.tb00780.x","article-title":"Glutaminyl-cyclase expression in the bovine\/porcine hypothalamus and pituitary","volume":"7","author":"B\u00f6ckers","year":"1995","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.bbr.2022.114020_bib28","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/nm.1872","article-title":"Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer\u2019s disease-like pathology","volume":"14","author":"Schilling","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbr.2022.114020_bib29","doi-asserted-by":"crossref","first-page":"12790","DOI":"10.1523\/JNEUROSCI.1794-11.2011","article-title":"Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated A\u03b2 is induced by pyroglutamate-A\u03b2 formation","volume":"31","author":"Alexandru","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2022.114020_bib30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-011-0806-2","article-title":"Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-A\u03b2 deposits in hippocampus via distinct cellular mechanisms","volume":"121","author":"Hartlage-R\u00fcbsamen","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2022.114020_bib31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature11060","article-title":"Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-\u03b2","volume":"485","author":"Nussbaum","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2022.114020_bib32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1471-4159.2008.05471.x","article-title":"Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical\/hippocampal microinjection in vivo\/in situ","volume":"106","author":"Schilling","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2022.114020_bib33","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1074\/jbc.M110.185819","article-title":"Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice","volume":"286","author":"Jawhar","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2022.114020_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neures.2012.03.010","article-title":"\u03b1-Synuclein BAC transgenic mice as a model for Parkinson\u2019s disease manifested decreased anxiety-like behavior and hyperlocomotion","volume":"73","author":"Yamakado","year":"2012","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbr.2022.114020_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbr.2018.11.035","article-title":"Treadmill exercise intervention improves gait and postural control in alpha-synuclein mouse models without inducing cerebral autophagy","volume":"363","author":"Minakaki","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2022.114020_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.bbr.2022.114020_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson\u2019s disease: The Thy1-aSyn (\u201cLine 61\u201d) mice","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbr.2022.114020_bib38","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/molecules23040924","article-title":"Immunohistochemical evidence from APP-Transgenic mice for glutaminyl cyclase as drug target to diminish pE-Abeta formation","volume":"23","author":"Hartlage-R\u00fcbsamen","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbr.2022.114020_bib39","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijdevneu.2009.08.007","article-title":"Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain","volume":"27","author":"Hartlage-R\u00fcbsamen","year":"2009","journal-title":"Int. J. Devl. Neurosci."},{"key":"10.1016\/j.bbr.2022.114020_bib40","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1111\/febs.15701","article-title":"Multifunctional intracellular matrix metalloproteinases: implications in disease","volume":"288","author":"Bassiouni","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.bbr.2022.114020_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40478-019-0717-3","article-title":"Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson\u2019s disease with cognitive decline","volume":"7","author":"Liu","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbr.2022.114020_bib42","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.bbamcr.2017.05.013","article-title":"New intracellular activities of matrix metalloproteinases shine in the moonlight","volume":"1864","author":"Jobin","year":"2017","journal-title":"Biochim Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.bbr.2022.114020_bib43","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2353\/ajpath.2006.060005","article-title":"Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis","volume":"169","author":"Si-Tayeb","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbr.2022.114020_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1471-4159.2008.05399.x","article-title":"A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells","volume":"106","author":"Choi","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2022.114020_bib45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuint.2009.09.014","article-title":"Matrix metalloproteinase-3 contributes to vulnerability of the nigral dopaminergic neurons","volume":"56","author":"Kim","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2022.114020_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/370526","article-title":"MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson\u2019s disease","volume":"2013","author":"Chung","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbr.2022.114020_bib47","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbr.2022.114020_bib48","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awu057","article-title":"Accumulation of oligomer-prone \u03b1-synuclein exacerbates synaptic and neuronal degeneration in vivo","volume":"137","author":"Rockenstein","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2022.114020_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbr.2022.114020_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10408363.2019.1711359","article-title":"Methods for detecting toxic alpha-synuclein species as a biomarker for Parkinson\u2019s disease","volume":"57","author":"O\u2019Hara","year":"2020","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.bbr.2022.114020_bib51","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.1093\/nar\/gkt794","article-title":"Principles of self-organization in biological pathways: a hypothesis on the autogenous association of alpha-synuclein","volume":"41","author":"Zanzoni","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bbr.2022.114020_bib52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/jnc.13570","article-title":"The contribution of alpha synuclein to neuronal survival and function \u2013 Implications for Parkinson\u2019s disease","volume":"137","author":"Benskey","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2022.114020_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00401-010-0685-y","article-title":"Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-A\u03b2 pathology in Alzheimer\u2019s disease","volume":"120","author":"Morawski","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2022.114020_bib54","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-131535","article-title":"Glutaminyl cyclases in human cortex \u2013 Correlation with (pGlu)-Abeta load and cognitive decline in Alzheimer\u2019s disease","volume":"39","author":"Morawski","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2022.114020_bib55","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1073\/pnas.080076097","article-title":"A decamer duplication in the 3\u2019 region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred","volume":"97","author":"Vidal","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbr.2022.114020_bib56","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.neurobiolaging.2012.11.014","article-title":"Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias","volume":"34","author":"Saul","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2022.114020_bib57","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1021\/bi900818a","article-title":"Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides","volume":"48","author":"Schlenzig","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbr.2022.114020_bib58","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1471-4159.2012.07707.x","article-title":"N-Terminal pyroglutamate formation of A\u03b238 and A\u03b240 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation","volume":"121","author":"Schlenzig","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2022.114020_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105478","article-title":"Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson\u2019s disease","volume":"158","author":"Torres","year":"2021","journal-title":"Neurobiol. Dis."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432822002881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432822002881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:23:12Z","timestamp":1778671392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432822002881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":59,"alternative-id":["S0166432822002881"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2022.114020","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha synuclein processing by MMP-3 \u2013 implications for synucleinopathies","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2022.114020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114020"}}